ENVIRONMENTAL RESEARCH GROUP OXFORD LIMITED

Their core work

ERGO is a UK-based environmental research SME specialising in vector-borne disease ecology — studying how pathogens spread through animal populations via insect vectors, and how environmental and climate conditions shape that spread. Their core work bridges veterinary epidemiology, entomology, and environmental science, with bluetongue virus (transmitted by Culicoides biting midges) as a flagship area of expertise. More recently they have expanded into epidemic intelligence and disease surveillance systems, applying big data methods to monitor outbreak events across the human-animal-environment interface. They contribute domain expertise — field knowledge of pathogen-vector-host-environment dynamics — to large multidisciplinary research consortia rather than building computational infrastructure themselves.

What they specialise in

How they've shifted over time

ERGO's first H2020 project (2017) was tightly focused on a single pathogen system — bluetongue virus, its insect vector Culicoides, and the epidemiology of infection in livestock — representing deep specialist knowledge in veterinary disease ecology. By 2020, their second project shifted toward broader epidemic intelligence: big data, outbreak monitoring, one health frameworks, and the influence of climate and environmental change on disease emergence. The trajectory is clear: from narrow pathogen-specific expertise toward a systems-level understanding of how diseases emerge and spread across species and environments, with data science as the new common thread.

ERGO is moving from species-specific disease ecology toward cross-disease, data-intensive surveillance, making them an increasingly relevant partner for one health platforms, climate-disease modelling, and outbreak preparedness consortia.

How they like to work

ERGO has never led an H2020 project — they join as a specialist participant, contributing domain knowledge within large multidisciplinary consortia. Despite only two projects, they have accumulated 41 distinct partners across 19 countries, which points to participation in broad international networks rather than small focused teams. This pattern suggests they are valued as a specific-expertise node — brought in for their environmental and epidemiological knowledge — rather than as a project architect or infrastructure provider.

ERGO has worked with 41 unique consortium partners across 19 countries from just two projects, indicating membership in large, geographically diverse research networks typical of EU-wide disease surveillance and animal health initiatives. Their network spans both veterinary/agricultural and public health communities, reflecting their one health positioning.

What sets them apart

ERGO occupies an uncommon niche as a private-sector SME with hands-on environmental and epidemiological research expertise in vector-borne diseases — a space typically dominated by university departments or government agencies. Their dual foothold in both veterinary disease ecology (PALE-Blu) and human-facing epidemic surveillance (MOOD) gives them credibility across the animal health and public health funding landscapes simultaneously. For a consortium builder, they offer specialist field and analytical expertise without the overhead of a large institution, and with a demonstrated ability to contribute productively to ambitious, multi-partner EU projects.

Highlights from their portfolio

• MOOD
  Their largest project by funding (EUR 391,938), MOOD represents a significant scope expansion — from a single livestock disease to a pan-European data science platform for monitoring infectious disease outbreaks across human, animal, and environmental health domains.
• PALE-Blu
  PALE-Blu established ERGO's scientific identity in H2020, placing them inside a focused European consortium tackling bluetongue — a climate-sensitive, economically damaging livestock disease with growing relevance as warmer temperatures extend Culicoides vector ranges northward.